Anne Fassbender

Title: Anne Fassbender: Innovator in Nucleic Acid Analysis

Introduction

Anne Fassbender is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of molecular biology, particularly in the analysis of cell proliferative disorders. With a total of 2 patents, her work focuses on improving diagnostic methods for conditions such as cancer.

Latest Patents

Fassbender's latest patents include innovative methods and nucleic acids for analyzing cell proliferative disorders. One of her notable inventions provides methods, nucleic acids, and kits for determining the prognosis of a subject with a cell proliferative disorder, preferably cancer. This invention discloses genomic sequences whose methylation patterns can enhance the detection of such disorders, thereby facilitating improved diagnosis and treatment for patients. Another patent details a method for determining the methylation pattern of a polynucleic acid, which involves preparing a solution of fragments, coupling them with detectable substances, and utilizing a DNA microarray for hybridization and detection.

Career Highlights

Anne Fassbender is currently associated with Epigenomics AG, where she continues to advance her research in the field of epigenetics. Her work has been instrumental in developing new diagnostic tools that can significantly impact patient care.

Collaborations

Fassbender collaborates with notable colleagues, including Ralf Lesche and Dimo Dietrich, who contribute to her research endeavors and innovations.

Conclusion

Anne Fassbender's contributions to the field of nucleic acid analysis exemplify her commitment to advancing medical diagnostics. Her innovative patents and ongoing research continue to pave the way for improved patient outcomes in the realm of cancer treatment.